Source: MarketScreener

Forma Therapeutics: Forma Therapeutics : Amendment to Initial Statement of Beneficial Ownership - Form 3/A

(marketscreener.com) Ownership Submission FORM 3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16 of the Securities Exchange Act of 1934 or Section 30 of the...https://www.marketscreener.com/quote/stock/FORMA-THERAPEUTICS-HOLDIN-108665623/news/Forma-Therapeutics-Amendment-to-Initial-Statement-of-Beneficial-Ownership-Form-3-A-41810415/?utm_medium=RSS&utm_content=20220919

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Frank D. Lee's photo - CEO of Forma Therapeutics

CEO

Frank D. Lee

CEO Approval Rating

90/100

Read more